The test examines key genetic markers including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313, mapping 49 specific peptides and 150+ genetic insights directly relevant to weight loss outcomes
As we noted in a recent update and earlier this year, telehealth companies, compounding pharmacies, medspas and other businesses promoting, manufacturing or facilitating access to compounded GLP-1 drugs should audit their advertising practices to take into account recent challenges and FDA activity
Special Advise Clinical monitoring of folic acid, vitamins B12 and B6 levels through blood examinations is recommended
Compliance of 130% was considered as non-compliant and any subject demonstrating non-compliance for two consecutive visits was withdrawn from the study
We offer a full range of treatments from nutritional guidance to medical support, ensuring you see long-term success